| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 2.85e-08 | 3 | 62 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 2.84e-07 | 5 | 62 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 2.74e-05 | 56 | 62 | 4 | GO:0030170 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 2.94e-05 | 57 | 62 | 4 | GO:0070279 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.10e-04 | 614 | 62 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | vitamin binding | 1.43e-04 | 161 | 62 | 5 | GO:0019842 | |
| GeneOntologyMolecularFunction | histone ubiquitin ligase activity | 6.14e-04 | 12 | 62 | 2 | GO:0140852 | |
| GeneOntologyMolecularFunction | histone modifying activity | 7.22e-04 | 229 | 62 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | profilin binding | 7.24e-04 | 13 | 62 | 2 | GO:0005522 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 8.43e-04 | 14 | 62 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | AMP binding | 1.92e-03 | 21 | 62 | 2 | GO:0016208 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.43e-03 | 441 | 62 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | cullin family protein binding | 2.94e-03 | 26 | 62 | 2 | GO:0097602 | |
| GeneOntologyBiologicalProcess | mesenchyme migration | 2.33e-07 | 5 | 60 | 3 | GO:0090131 | |
| GeneOntologyBiologicalProcess | positive regulation of protein neddylation | 8.27e-05 | 5 | 60 | 2 | GO:2000436 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | DCAF1 TLK1 PBRM1 BRF1 NAP1L2 CHD6 SUZ12 HUWE1 TASOR KAT14 TRIM37 | 1.26e-04 | 999 | 60 | 11 | GO:0071824 |
| GeneOntologyBiologicalProcess | glycogen catabolic process | 1.43e-04 | 35 | 60 | 3 | GO:0005980 | |
| GeneOntologyBiologicalProcess | glucan catabolic process | 1.56e-04 | 36 | 60 | 3 | GO:0009251 | |
| GeneOntologyBiologicalProcess | skeletal muscle thin filament assembly | 1.73e-04 | 7 | 60 | 2 | GO:0030240 | |
| GeneOntologyBiologicalProcess | polysaccharide catabolic process | 1.84e-04 | 38 | 60 | 3 | GO:0000272 | |
| GeneOntologyBiologicalProcess | chromatin organization | 2.38e-04 | 896 | 60 | 10 | GO:0006325 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.72e-04 | 741 | 60 | 9 | GO:0006338 | |
| Domain | PHOSPHORYLASE | 3.15e-08 | 3 | 60 | 3 | PS00102 | |
| Domain | Phosphorylase | 3.15e-08 | 3 | 60 | 3 | PF00343 | |
| Domain | Glycg_phsphrylas | 3.15e-08 | 3 | 60 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 3.15e-08 | 3 | 60 | 3 | IPR000811 | |
| Domain | ACTINS_1 | 1.74e-06 | 8 | 60 | 3 | PS00406 | |
| Domain | Actin_CS | 1.71e-05 | 16 | 60 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 2.08e-05 | 17 | 60 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.49e-05 | 18 | 60 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 2.94e-05 | 19 | 60 | 3 | PS01132 | |
| Domain | DCN-prot | 1.01e-04 | 5 | 60 | 2 | IPR014764 | |
| Domain | PONY_dom | 1.01e-04 | 5 | 60 | 2 | IPR005176 | |
| Domain | DCUN1 | 1.01e-04 | 5 | 60 | 2 | PS51229 | |
| Domain | Cullin_binding | 1.01e-04 | 5 | 60 | 2 | PF03556 | |
| Domain | Actin | 1.33e-04 | 31 | 60 | 3 | IPR004000 | |
| Domain | Actin | 1.33e-04 | 31 | 60 | 3 | PF00022 | |
| Domain | ACTIN | 1.33e-04 | 31 | 60 | 3 | SM00268 | |
| Domain | Cullin | 4.49e-04 | 10 | 60 | 2 | PF00888 | |
| Domain | CULLIN_2 | 4.49e-04 | 10 | 60 | 2 | PS50069 | |
| Domain | Cullin_N | 4.49e-04 | 10 | 60 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 4.49e-04 | 10 | 60 | 2 | PS01256 | |
| Domain | UBA-like | 1.14e-03 | 64 | 60 | 3 | IPR009060 | |
| Domain | HECT | 3.38e-03 | 27 | 60 | 2 | PF00632 | |
| Domain | HECTc | 3.38e-03 | 27 | 60 | 2 | SM00119 | |
| Domain | HECT_dom | 3.38e-03 | 27 | 60 | 2 | IPR000569 | |
| Domain | HECT | 3.38e-03 | 27 | 60 | 2 | PS50237 | |
| Domain | ARM-type_fold | 4.62e-03 | 339 | 60 | 5 | IPR016024 | |
| Domain | Helicase_C | 4.94e-03 | 107 | 60 | 3 | PF00271 | |
| Domain | HELICc | 4.94e-03 | 107 | 60 | 3 | SM00490 | |
| Domain | Helicase_C | 5.07e-03 | 108 | 60 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 5.20e-03 | 109 | 60 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.20e-03 | 109 | 60 | 3 | PS51192 | |
| Domain | DEXDc | 5.20e-03 | 109 | 60 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.33e-03 | 110 | 60 | 3 | IPR014001 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 5.64e-03 | 35 | 60 | 2 | IPR002464 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION | 3.47e-06 | 9 | 50 | 3 | M47621 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 1.49e-05 | 14 | 50 | 3 | M19193 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 9.14e-05 | 25 | 50 | 3 | M27857 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 2.33e-04 | 34 | 50 | 3 | MM15985 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 3.25e-04 | 38 | 50 | 3 | M39549 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 3.78e-04 | 40 | 50 | 3 | M39595 | |
| Pathway | BIOCARTA_FEEDER_PATHWAY | 4.37e-04 | 9 | 50 | 2 | M3061 | |
| Pathway | WP_TRANSSULFURATION_PATHWAY | 5.45e-04 | 10 | 50 | 2 | M39324 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 6.10e-04 | 47 | 50 | 3 | M39829 | |
| Pathway | WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS | 6.64e-04 | 11 | 50 | 2 | M39741 | |
| Pathway | WP_SPINA_BIFIDA | 7.95e-04 | 12 | 50 | 2 | M48321 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 8.21e-04 | 52 | 50 | 3 | M14171 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 1.09e-03 | 14 | 50 | 2 | MM15391 | |
| Pathway | REACTOME_METHYLATION | 1.09e-03 | 14 | 50 | 2 | MM14596 | |
| Pathway | REACTOME_METHYLATION | 1.09e-03 | 14 | 50 | 2 | M26967 | |
| Pathway | WP_CYSTEINE_AND_METHIONINE_CATABOLISM | 1.26e-03 | 15 | 50 | 2 | M39790 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HSPD1 DHX15 ACSL1 SPTLC2 ACTA1 ACTA2 AHCY MTR ACTC1 PYGB PYGL HUWE1 RFC1 DNAJC7 HECTD1 HNRNPL | 4.40e-10 | 1257 | 62 | 16 | 37317656 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BRF1 DIAPH1 MTR ACTC1 CUL9 PYGB HUWE1 MTREX DNAJC7 KAT14 TRIM37 RBM20 | 4.89e-10 | 588 | 62 | 12 | 38580884 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | HSPD1 DHX15 DCAF1 PBRM1 PCLO ACTA1 ACTA2 CUL9 PARD3B HUWE1 HECTD1 TRIM37 | 1.25e-09 | 639 | 62 | 12 | 23443559 |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 5.39e-09 | 3 | 62 | 3 | 7780165 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | HSPD1 DCAF1 DCUN1D1 DCUN1D2 ACTA2 AHCY DIAPH1 PYGL HUWE1 DNAJC7 | 1.73e-08 | 495 | 62 | 10 | 28581483 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.88e-08 | 271 | 62 | 8 | 32433965 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.65e-08 | 398 | 62 | 9 | 35016035 | |
| Pubmed | HSPD1 DHX15 ZC3H4 AHCY SCAF11 HUWE1 MTREX DNAJC7 TASOR HNRNPL | 4.72e-08 | 551 | 62 | 10 | 34728620 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 DHX15 DCAF1 ACSL1 SPTLC2 AHCY DIAPH1 PYGB PYGL HUWE1 RFC1 MTREX HNRNPL TP53BP2 | 8.60e-08 | 1353 | 62 | 14 | 29467282 |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 1.07e-07 | 6 | 62 | 3 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 1.07e-07 | 6 | 62 | 3 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 1.07e-07 | 6 | 62 | 3 | 11709093 | |
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 1.07e-07 | 6 | 62 | 3 | 9971772 | |
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 10049817 | ||
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 1.07e-07 | 6 | 62 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 1.07e-07 | 6 | 62 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 1.07e-07 | 6 | 62 | 3 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 1.07e-07 | 6 | 62 | 3 | 8661406 | |
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 23017337 | ||
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 1.07e-07 | 6 | 62 | 3 | 10074138 | |
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 1.07e-07 | 6 | 62 | 3 | 23875777 | |
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 9841925 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 1.43e-07 | 621 | 62 | 10 | 22794259 | |
| Pubmed | 1.47e-07 | 469 | 62 | 9 | 27634302 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | HSPD1 DHX15 DCAF1 ZC3H4 ACTA1 SCAF11 HUWE1 RFC1 MTREX DNAJC7 HNRNPL NOL8 | 1.53e-07 | 989 | 62 | 12 | 36424410 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 1.79e-07 | 344 | 62 | 8 | 36282215 | |
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 1.88e-07 | 7 | 62 | 3 | 17504171 | |
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 22535526 | ||
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 22465675 | ||
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 1.88e-07 | 7 | 62 | 3 | 9384381 | |
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 30289203 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 1.88e-07 | 7 | 62 | 3 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 1.88e-07 | 7 | 62 | 3 | 22640593 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.99e-07 | 486 | 62 | 9 | 30940648 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 DHX15 DCUN1D1 ACTA1 AHCY DIAPH1 MTR PPME1 PYGB PYGL EEF2K HUWE1 DNAJC7 HECTD1 | 2.09e-07 | 1455 | 62 | 14 | 22863883 |
| Pubmed | 2.27e-07 | 653 | 62 | 10 | 22586326 | ||
| Pubmed | HSPD1 DHX15 ACTA1 ACTA2 AHCY ACTC1 PYGB PYGL PYGM DNAJC7 HNRNPL | 2.65e-07 | 844 | 62 | 11 | 25963833 | |
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 14694110 | ||
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 20147394 | ||
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 23260110 | ||
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 20096780 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HSPD1 DHX15 PBRM1 ACTA1 SCAF11 CHD6 SUZ12 RFC1 MTREX TASOR KAT14 HNRNPL NOL8 | 3.75e-07 | 1294 | 62 | 13 | 30804502 |
| Pubmed | Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. | 4.50e-07 | 9 | 62 | 3 | 12297046 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 4.50e-07 | 9 | 62 | 3 | 8892894 | |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 4.50e-07 | 9 | 62 | 3 | 10556093 | |
| Pubmed | 4.50e-07 | 9 | 62 | 3 | 18775311 | ||
| Pubmed | Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. | 6.42e-07 | 10 | 62 | 3 | 21749862 | |
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 6.42e-07 | 10 | 62 | 3 | 1991513 | |
| Pubmed | 6.42e-07 | 10 | 62 | 3 | 23575248 | ||
| Pubmed | 6.42e-07 | 10 | 62 | 3 | 1907279 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSPD1 DHX15 ZC3H4 ACTA2 AHCY DIAPH1 ACTC1 PYGL HUWE1 RFC1 DNAJC7 HNRNPL | 7.51e-07 | 1149 | 62 | 12 | 35446349 |
| Pubmed | 8.81e-07 | 11 | 62 | 3 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 8.81e-07 | 11 | 62 | 3 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 8.81e-07 | 11 | 62 | 3 | 19639585 | |
| Pubmed | 8.81e-07 | 11 | 62 | 3 | 22207710 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HSPD1 DHX15 ZC3H4 ACTA1 AHCY DIAPH1 SCAF11 HUWE1 RFC1 MTREX DNAJC7 HECTD1 HNRNPL | 1.03e-06 | 1415 | 62 | 13 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSPD1 DHX15 PBRM1 PCLO AHCY DIAPH1 MTR SUZ12 HUWE1 RFC1 MTREX DNAJC7 HNRNPL | 1.11e-06 | 1425 | 62 | 13 | 30948266 |
| Pubmed | HSPD1 SOX6 C3P1 PBRM1 MTR CUL9 SCAF11 CHD6 RFC1 DNAJC7 KAT14 RBM20 HNRNPL | 1.14e-06 | 1429 | 62 | 13 | 35140242 | |
| Pubmed | 1.17e-06 | 12 | 62 | 3 | 23071112 | ||
| Pubmed | SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice. | 1.17e-06 | 12 | 62 | 3 | 31042497 | |
| Pubmed | Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. | 1.52e-06 | 13 | 62 | 3 | 18400219 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSPD1 DHX15 PBRM1 ZC3H4 ACTA1 AHCY ACTC1 HUWE1 MTREX DNAJC7 HNRNPL | 1.76e-06 | 1024 | 62 | 11 | 24711643 |
| Pubmed | HSPD1 DHX15 AHCY ASCC1 DIAPH1 HUWE1 RFC1 MTREX DNAJC7 HECTD1 HNRNPL TP53BP2 | 1.76e-06 | 1247 | 62 | 12 | 27684187 | |
| Pubmed | 1.80e-06 | 634 | 62 | 9 | 34591612 | ||
| Pubmed | 1.94e-06 | 14 | 62 | 3 | 21923909 | ||
| Pubmed | 1.94e-06 | 14 | 62 | 3 | 17411366 | ||
| Pubmed | SOX6 CFH AHCY NAP1L2 NAV3 PPME1 CUL9 CHD6 HUWE1 DNAJC7 HECTD1 TRIM37 | 2.40e-06 | 1285 | 62 | 12 | 35914814 | |
| Pubmed | 2.42e-06 | 15 | 62 | 3 | 2575583 | ||
| Pubmed | 2.42e-06 | 15 | 62 | 3 | 24598388 | ||
| Pubmed | A catalogue of putative HIV-1 protease host cell substrates. | 2.92e-06 | 124 | 62 | 5 | 22944692 | |
| Pubmed | Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose. | 2.97e-06 | 16 | 62 | 3 | 16638982 | |
| Pubmed | Serum response factor is essential for mesoderm formation during mouse embryogenesis. | 2.97e-06 | 16 | 62 | 3 | 9799237 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HSPD1 DHX15 PBRM1 DIAPH1 ACTC1 PPME1 PYGL CHD6 HUWE1 RFC1 MTREX HNRNPL | 3.12e-06 | 1318 | 62 | 12 | 30463901 |
| Pubmed | Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. | 3.13e-06 | 2 | 62 | 2 | 19468071 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 20706863 | ||
| Pubmed | alpha-Actin proteins and gene transcripts are colocalized in embryonic mouse muscle. | 3.13e-06 | 2 | 62 | 2 | 1893870 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 3023046 | ||
| Pubmed | Muscle specific expression of Cre recombinase under two actin promoters in transgenic mice. | 3.13e-06 | 2 | 62 | 2 | 10686609 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 3075543 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 25130497 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 2731651 | ||
| Pubmed | A fetal skeletal muscle actin mRNA in the mouse and its identity with cardiac actin mRNA. | 3.13e-06 | 2 | 62 | 2 | 6897014 | |
| Pubmed | 3.23e-06 | 506 | 62 | 8 | 30890647 | ||
| Pubmed | HSPD1 DHX15 DCAF1 ACTA2 AHCY ASCC1 HUWE1 RFC1 MTREX DNAJC7 HECTD1 HNRNPL | 3.56e-06 | 1335 | 62 | 12 | 29229926 | |
| Pubmed | 3.60e-06 | 17 | 62 | 3 | 17360745 | ||
| Pubmed | 3.60e-06 | 17 | 62 | 3 | 8997639 | ||
| Pubmed | 3.90e-06 | 234 | 62 | 6 | 36243803 | ||
| Pubmed | 4.32e-06 | 18 | 62 | 3 | 24840128 | ||
| Pubmed | 4.32e-06 | 18 | 62 | 3 | 15929941 | ||
| Pubmed | 4.59e-06 | 136 | 62 | 5 | 26979993 | ||
| Pubmed | 4.96e-06 | 244 | 62 | 6 | 29884807 | ||
| Pubmed | 5.12e-06 | 19 | 62 | 3 | 30700554 | ||
| Pubmed | Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation. | 5.12e-06 | 19 | 62 | 3 | 26389696 | |
| Pubmed | Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. | 5.12e-06 | 19 | 62 | 3 | 18316483 | |
| Pubmed | 5.57e-06 | 249 | 62 | 6 | 30097533 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 6.53e-06 | 256 | 62 | 6 | 32698014 | |
| Pubmed | 6.77e-06 | 560 | 62 | 8 | 35241646 | ||
| Pubmed | 7.01e-06 | 21 | 62 | 3 | 20230754 | ||
| Pubmed | Myocardial Mycn is essential for mouse ventricular wall morphogenesis. | 7.01e-06 | 21 | 62 | 3 | 23063798 | |
| Interaction | SNRNP40 interactions | TLK1 ZC3H4 ACTC1 CUL9 SCAF11 SUZ12 RFC1 MTREX HECTD1 TASOR RBM20 HNRNPL NOL8 | 4.53e-08 | 637 | 61 | 13 | int:SNRNP40 |
| Interaction | OBSL1 interactions | HSPD1 DHX15 PBRM1 ZC3H4 PCLO ACTA1 ACTC1 CUL9 SUZ12 HUWE1 RFC1 MTREX DNAJC7 HECTD1 HNRNPL | 5.28e-08 | 902 | 61 | 15 | int:OBSL1 |
| Interaction | DPPA4 interactions | 2.14e-07 | 140 | 61 | 7 | int:DPPA4 | |
| Interaction | POTEJ interactions | 5.01e-07 | 52 | 61 | 5 | int:POTEJ | |
| Interaction | ACTC1 interactions | HSPD1 DHX15 TLK1 ZC3H4 ACTA1 ACTA2 DIAPH1 ACTC1 CUL9 SUZ12 KAT14 TRIM37 | 9.38e-07 | 694 | 61 | 12 | int:ACTC1 |
| Interaction | TOP1 interactions | DCAF1 PBRM1 ZC3H4 DIAPH1 PYGM SCAF11 SUZ12 RFC1 MTREX HECTD1 TASOR HNRNPL | 9.66e-07 | 696 | 61 | 12 | int:TOP1 |
| Interaction | C9orf72 interactions | HSPD1 DHX15 ACSL1 SPTLC2 ACTA1 ACTA2 AHCY MTR ACTC1 PYGB PYGL HUWE1 RFC1 DNAJC7 HECTD1 HNRNPL | 1.27e-06 | 1319 | 61 | 16 | int:C9orf72 |
| Interaction | ZNF677 interactions | 1.27e-06 | 27 | 61 | 4 | int:ZNF677 | |
| Interaction | CUL1 interactions | HSPD1 DHX15 DCAF1 DCUN1D1 DCUN1D2 ACTA1 ACTA2 AHCY NAP1L2 HUWE1 RFC1 MTREX HNRNPL | 1.71e-06 | 876 | 61 | 13 | int:CUL1 |
| Interaction | SNW1 interactions | HSPD1 DHX15 ACTA1 AHCY DIAPH1 ACTC1 SUZ12 HUWE1 MTREX DNAJC7 HECTD1 TRIM37 | 2.02e-06 | 747 | 61 | 12 | int:SNW1 |
| Interaction | PYGL interactions | 2.12e-06 | 125 | 61 | 6 | int:PYGL | |
| Interaction | CAND1 interactions | HSPD1 DHX15 DCUN1D1 TENM4 DCUN1D2 ACTA2 AHCY PYGB SUZ12 HUWE1 MTREX HECTD1 HNRNPL | 2.14e-06 | 894 | 61 | 13 | int:CAND1 |
| Interaction | EIF4A3 interactions | DHX15 ACTC1 CUL9 EEF2K SUZ12 HUWE1 MTREX HECTD1 RBM20 HNRNPL | 2.30e-06 | 499 | 61 | 10 | int:EIF4A3 |
| Interaction | CHD3 interactions | HSPD1 DHX15 SOX6 PBRM1 ACTC1 SCAF11 CHD6 SUZ12 RFC1 MTREX HECTD1 HNRNPL | 2.32e-06 | 757 | 61 | 12 | int:CHD3 |
| Interaction | PPP1R9B interactions | HSPD1 BRF1 PCLO ACTA1 ACTA2 ACTC1 PYGB PYGM SUZ12 TRIM37 HNRNPL | 2.43e-06 | 626 | 61 | 11 | int:PPP1R9B |
| Interaction | BRD7 interactions | HSPD1 DHX15 PBRM1 ZC3H4 ACTA1 ACTA2 ACTC1 SUZ12 HUWE1 RFC1 DNAJC7 | 2.87e-06 | 637 | 61 | 11 | int:BRD7 |
| Interaction | SENP3 interactions | 3.34e-06 | 301 | 61 | 8 | int:SENP3 | |
| Interaction | FLNB interactions | 3.60e-06 | 304 | 61 | 8 | int:FLNB | |
| Interaction | TRRAP interactions | HSPD1 DHX15 DCUN1D1 TENT5A ACTC1 CHD6 SUZ12 DNAJC7 HECTD1 TASOR KAT14 HNRNPL | 3.60e-06 | 790 | 61 | 12 | int:TRRAP |
| Interaction | NCL interactions | HSPD1 DHX15 DCAF1 DCUN1D1 BRF1 SUZ12 HUWE1 RFC1 MTREX HECTD1 TRIM37 HNRNPL | 3.99e-06 | 798 | 61 | 12 | int:NCL |
| Interaction | PLEC interactions | 5.47e-06 | 430 | 61 | 9 | int:PLEC | |
| Interaction | ATAD3A interactions | 6.57e-06 | 330 | 61 | 8 | int:ATAD3A | |
| Interaction | PABPC4 interactions | 6.83e-06 | 442 | 61 | 9 | int:PABPC4 | |
| Interaction | NPHP4 interactions | 7.04e-06 | 236 | 61 | 7 | int:NPHP4 | |
| Interaction | NUP50 interactions | 8.35e-06 | 341 | 61 | 8 | int:NUP50 | |
| Interaction | PFN2 interactions | 8.51e-06 | 159 | 61 | 6 | int:PFN2 | |
| Interaction | STYXL1 interactions | 1.03e-05 | 45 | 61 | 4 | int:STYXL1 | |
| Interaction | SIRT7 interactions | DHX15 DCAF1 PBRM1 CUL9 PYGB PYGL SCAF11 HUWE1 RFC1 MTREX HECTD1 | 1.25e-05 | 744 | 61 | 11 | int:SIRT7 |
| Interaction | FUS interactions | HSPD1 DHX15 DCUN1D1 PBRM1 ZC3H4 AHCY ACTC1 SUZ12 MTREX DNAJC7 HNRNPL | 1.47e-05 | 757 | 61 | 11 | int:FUS |
| Interaction | POTEI interactions | 1.65e-05 | 105 | 61 | 5 | int:POTEI | |
| Interaction | MCM2 interactions | HSPD1 DHX15 ACTA1 ACTA2 AHCY ACTC1 PYGB PYGL PYGM SUZ12 HUWE1 DNAJC7 HNRNPL | 1.68e-05 | 1081 | 61 | 13 | int:MCM2 |
| Interaction | PFN1 interactions | 2.10e-05 | 509 | 61 | 9 | int:PFN1 | |
| Interaction | SUZ12 interactions | HSPD1 PBRM1 ACTC1 PYGL PARD3B SCAF11 SUZ12 HECTD1 TASOR TRIM37 | 2.15e-05 | 644 | 61 | 10 | int:SUZ12 |
| Interaction | HTT interactions | HSPD1 DHX15 ACSL1 PCLO ACTA1 AHCY PYGB PYGL PYGM SUZ12 HUWE1 HNRNPL | 2.28e-05 | 949 | 61 | 12 | int:HTT |
| Interaction | UBE2M interactions | HSPD1 DCAF1 DCUN1D1 DCUN1D2 ACTA2 AHCY DIAPH1 PYGL HUWE1 DNAJC7 | 2.35e-05 | 651 | 61 | 10 | int:UBE2M |
| Interaction | U2AF2 interactions | HSPD1 DHX15 ACTA1 SCAF11 SUZ12 HUWE1 DNAJC7 HECTD1 TRIM37 HNRNPL | 2.35e-05 | 651 | 61 | 10 | int:U2AF2 |
| Interaction | SNRPB interactions | 2.38e-05 | 517 | 61 | 9 | int:SNRPB | |
| Interaction | PABPN1 interactions | 2.48e-05 | 192 | 61 | 6 | int:PABPN1 | |
| Interaction | CYB5D1 interactions | 2.70e-05 | 3 | 61 | 2 | int:CYB5D1 | |
| Interaction | SCAF8 interactions | 3.05e-05 | 59 | 61 | 4 | int:SCAF8 | |
| Interaction | SNRPD2 interactions | 3.37e-05 | 414 | 61 | 8 | int:SNRPD2 | |
| Interaction | GAPDH interactions | 3.67e-05 | 686 | 61 | 10 | int:GAPDH | |
| Interaction | H2BC21 interactions | 4.15e-05 | 696 | 61 | 10 | int:H2BC21 | |
| Interaction | RBX1 interactions | 4.31e-05 | 558 | 61 | 9 | int:RBX1 | |
| Interaction | CUL4A interactions | HSPD1 DHX15 DCAF1 TLK1 DCUN1D1 NADSYN1 DCUN1D2 SCAF11 SUZ12 KAT14 HNRNPL | 4.45e-05 | 854 | 61 | 11 | int:CUL4A |
| Interaction | KBTBD4 interactions | 4.61e-05 | 316 | 61 | 7 | int:KBTBD4 | |
| Interaction | CAP2 interactions | 4.76e-05 | 66 | 61 | 4 | int:CAP2 | |
| Interaction | RBM17 interactions | 5.06e-05 | 218 | 61 | 6 | int:RBM17 | |
| Interaction | NUCKS1 interactions | 5.32e-05 | 220 | 61 | 6 | int:NUCKS1 | |
| Interaction | MAPKAPK2 interactions | 5.32e-05 | 134 | 61 | 5 | int:MAPKAPK2 | |
| Interaction | RBM5 interactions | 5.51e-05 | 135 | 61 | 5 | int:RBM5 | |
| Interaction | POU5F1 interactions | 6.13e-05 | 584 | 61 | 9 | int:POU5F1 | |
| Interaction | DDX46 interactions | 6.33e-05 | 227 | 61 | 6 | int:DDX46 | |
| Interaction | CDCA5 interactions | 6.55e-05 | 140 | 61 | 5 | int:CDCA5 | |
| Interaction | ILF2 interactions | 6.63e-05 | 590 | 61 | 9 | int:ILF2 | |
| Interaction | FASN interactions | DHX15 ACSL1 TLK1 DCUN1D1 PBRM1 SPTLC2 AHCY ACTC1 PPME1 HUWE1 DNAJC7 KAT14 | 6.83e-05 | 1062 | 61 | 12 | int:FASN |
| Interaction | MACROH2A1 interactions | 6.86e-05 | 458 | 61 | 8 | int:MACROH2A1 | |
| Interaction | SNRNP200 interactions | 7.07e-05 | 460 | 61 | 8 | int:SNRNP200 | |
| Interaction | SF3A3 interactions | 7.30e-05 | 340 | 61 | 7 | int:SF3A3 | |
| Interaction | UBE2F interactions | 7.33e-05 | 27 | 61 | 3 | int:UBE2F | |
| Interaction | NTF3 interactions | 7.33e-05 | 27 | 61 | 3 | int:NTF3 | |
| Interaction | EFTUD2 interactions | HSPD1 DHX15 BRF1 ZC3H4 ACTA1 AHCY DIAPH1 CUL9 SCAF11 SUZ12 HUWE1 RFC1 MTREX HECTD1 | 8.45e-05 | 1449 | 61 | 14 | int:EFTUD2 |
| Interaction | GTF3C1 interactions | 8.81e-05 | 241 | 61 | 6 | int:GTF3C1 | |
| Interaction | RUFY1 interactions | 8.97e-05 | 476 | 61 | 8 | int:RUFY1 | |
| Interaction | LCOR interactions | 9.01e-05 | 242 | 61 | 6 | int:LCOR | |
| Interaction | PRMT1 interactions | HSPD1 DHX15 ZC3H4 AHCY SCAF11 SUZ12 HUWE1 MTREX DNAJC7 TASOR HNRNPL | 9.49e-05 | 929 | 61 | 11 | int:PRMT1 |
| Interaction | C9orf78 interactions | 9.69e-05 | 620 | 61 | 9 | int:C9orf78 | |
| Interaction | RALY interactions | 9.73e-05 | 356 | 61 | 7 | int:RALY | |
| Interaction | COPS5 interactions | HSPD1 DHX15 DCAF1 DCUN1D1 ACTA2 AHCY PPME1 PYGL HUWE1 MTREX HECTD1 HNRNPL | 9.73e-05 | 1102 | 61 | 12 | int:COPS5 |
| Interaction | SNRPA interactions | 9.78e-05 | 482 | 61 | 8 | int:SNRPA | |
| Interaction | LRRFIP1 interactions | 9.98e-05 | 153 | 61 | 5 | int:LRRFIP1 | |
| Interaction | MECOM interactions | 1.01e-04 | 358 | 61 | 7 | int:MECOM | |
| Interaction | DHX40 interactions | 1.05e-04 | 249 | 61 | 6 | int:DHX40 | |
| Interaction | FSCN1 interactions | 1.10e-04 | 251 | 61 | 6 | int:FSCN1 | |
| Interaction | DYNC1H1 interactions | 1.11e-04 | 491 | 61 | 8 | int:DYNC1H1 | |
| Interaction | PAGE4 interactions | 1.15e-04 | 253 | 61 | 6 | int:PAGE4 | |
| Interaction | RCOR1 interactions | 1.16e-04 | 494 | 61 | 8 | int:RCOR1 | |
| Interaction | ARL16 interactions | 1.17e-04 | 83 | 61 | 4 | int:ARL16 | |
| Interaction | TEX101 interactions | 1.20e-04 | 255 | 61 | 6 | int:TEX101 | |
| Interaction | PCNA interactions | 1.21e-04 | 497 | 61 | 8 | int:PCNA | |
| Interaction | PUF60 interactions | 1.22e-04 | 369 | 61 | 7 | int:PUF60 | |
| Interaction | SKI interactions | 1.23e-04 | 160 | 61 | 5 | int:SKI | |
| Interaction | HNRNPAB interactions | 1.26e-04 | 371 | 61 | 7 | int:HNRNPAB | |
| Interaction | PARP1 interactions | NADSYN1 PBRM1 BRF1 SCAF11 CHD6 SUZ12 HUWE1 RFC1 MTREX HECTD1 TRIM37 HNRNPL NOL8 | 1.28e-04 | 1316 | 61 | 13 | int:PARP1 |
| Interaction | ABHD16B interactions | 1.34e-04 | 6 | 61 | 2 | int:ABHD16B | |
| Interaction | TLE3 interactions | 1.37e-04 | 376 | 61 | 7 | int:TLE3 | |
| Interaction | PRDX1 interactions | 1.43e-04 | 379 | 61 | 7 | int:PRDX1 | |
| Interaction | XPO6 interactions | 1.46e-04 | 88 | 61 | 4 | int:XPO6 | |
| Interaction | CLTC interactions | 1.47e-04 | 655 | 61 | 9 | int:CLTC | |
| Interaction | SEPTIN9 interactions | 1.48e-04 | 265 | 61 | 6 | int:SEPTIN9 | |
| Interaction | XRN2 interactions | 1.48e-04 | 381 | 61 | 7 | int:XRN2 | |
| Interaction | HECTD1 interactions | HSPD1 PBRM1 SCAF11 SUZ12 HUWE1 RFC1 MTREX HECTD1 TASOR HNRNPL NOL8 | 1.58e-04 | 984 | 61 | 11 | int:HECTD1 |
| Interaction | SNRNP70 interactions | DHX15 DCUN1D1 ARSF ZC3H4 ACTC1 SCAF11 SUZ12 RFC1 MTREX HECTD1 HNRNPL | 1.58e-04 | 984 | 61 | 11 | int:SNRNP70 |
| Interaction | NEXN interactions | 1.67e-04 | 91 | 61 | 4 | int:NEXN | |
| Interaction | FARSB interactions | 1.68e-04 | 171 | 61 | 5 | int:FARSB | |
| Interaction | ABRA interactions | 1.75e-04 | 36 | 61 | 3 | int:ABRA | |
| Interaction | CPSF6 interactions | 1.78e-04 | 526 | 61 | 8 | int:CPSF6 | |
| Interaction | DNASE1 interactions | 1.87e-04 | 7 | 61 | 2 | int:DNASE1 | |
| Interaction | ANKRD12 interactions | 1.91e-04 | 37 | 61 | 3 | int:ANKRD12 | |
| Interaction | MYO6 interactions | 1.94e-04 | 398 | 61 | 7 | int:MYO6 | |
| GeneFamily | Glycogen phosphorylases | 1.00e-08 | 3 | 40 | 3 | 437 | |
| GeneFamily | Actins | 2.00e-07 | 6 | 40 | 3 | 929 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | DCUN1D1 PBRM1 TENT5A MTR SCAF11 SUZ12 RFC1 MTREX DNAJC7 HECTD1 TASOR | 3.54e-07 | 656 | 62 | 11 | M18979 |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 7.89e-06 | 200 | 62 | 6 | M78 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.37e-05 | 466 | 62 | 8 | M13522 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 3.02e-05 | 856 | 62 | 10 | M4500 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 4.51e-05 | 165 | 62 | 5 | M8121 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP | 1.07e-04 | 198 | 62 | 5 | M5152 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | 1.09e-04 | 199 | 62 | 5 | M5268 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 1.12e-04 | 200 | 62 | 5 | M4538 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 1.12e-04 | 200 | 62 | 5 | M7444 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_500 | 3.96e-06 | 38 | 60 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100 | 5.32e-05 | 26 | 60 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_100 | 6.68e-05 | 77 | 60 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100 | 6.68e-05 | 28 | 60 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k3 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#1_top-relative-expression-ranked_200 | 1.21e-04 | 34 | 60 | 3 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k1_200 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.23e-04 | 90 | 60 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_k1_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.76e-04 | 293 | 60 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 2.05e-04 | 905 | 60 | 10 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.81e-07 | 192 | 62 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.90e-07 | 193 | 62 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.90e-07 | 193 | 62 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 2.99e-07 | 194 | 62 | 6 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 2.99e-07 | 194 | 62 | 6 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-06 | 175 | 62 | 5 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 184 | 62 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 184 | 62 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 184 | 62 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.28e-06 | 187 | 62 | 5 | 69b47f00598d647e2a99427ebddf42c339428e47 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 6.44e-06 | 188 | 62 | 5 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-06 | 192 | 62 | 5 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-06 | 192 | 62 | 5 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 196 | 62 | 5 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 196 | 62 | 5 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nts|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.98e-05 | 127 | 62 | 4 | ace2944328529fa029ee56c7ad3b0f283511d3bb | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 154 | 62 | 4 | 73de626b210ec5482ba89a65e784c1e77ff2894e | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 154 | 62 | 4 | 56fe9953e58f71626d3ddf63d340ed35dfc4ce9f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.86e-05 | 163 | 62 | 4 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.86e-05 | 163 | 62 | 4 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.46e-05 | 171 | 62 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 173 | 62 | 4 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 173 | 62 | 4 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 173 | 62 | 4 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 1.03e-04 | 175 | 62 | 4 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 175 | 62 | 4 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 175 | 62 | 4 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 176 | 62 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-04 | 178 | 62 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 15-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 1.13e-04 | 179 | 62 | 4 | bc04789f0fbd293fdcea66acba8cf227af251b7a | |
| ToppCell | facs-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 180 | 62 | 4 | c0c3144011856d005aebd5cdc79f89fee32083a8 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 180 | 62 | 4 | 87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 182 | 62 | 4 | c4a7007c864a9455a7e7447e28ccd380878a6a0f | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 182 | 62 | 4 | edfc598b7199ca1d8a399b264ab863c299b1eede | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 182 | 62 | 4 | c315d820ffad912c014ba5eac6f5fa6de1a94384 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 182 | 62 | 4 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-04 | 183 | 62 | 4 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 183 | 62 | 4 | 8de4b616a06be03e1cb6ae6a9ce6bf06485629d3 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.25e-04 | 184 | 62 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 184 | 62 | 4 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 186 | 62 | 4 | aa88d9573a237b2b8e6025fee31f69fbce824497 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 186 | 62 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 186 | 62 | 4 | 26458ff8cad5577de4306cffa0ca69eb26940e0d | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 186 | 62 | 4 | a71397efc68d2916ddc373d92cfd07be58033e1c | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 186 | 62 | 4 | ecc5acd111a6ee50d59544d1bdd7ed94e2812aae | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.31e-04 | 186 | 62 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 186 | 62 | 4 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 187 | 62 | 4 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 187 | 62 | 4 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 187 | 62 | 4 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 187 | 62 | 4 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.34e-04 | 187 | 62 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 187 | 62 | 4 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 62 | 4 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 62 | 4 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 1.36e-04 | 188 | 62 | 4 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.39e-04 | 189 | 62 | 4 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 190 | 62 | 4 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.42e-04 | 190 | 62 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 190 | 62 | 4 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 191 | 62 | 4 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 191 | 62 | 4 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 191 | 62 | 4 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 191 | 62 | 4 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.48e-04 | 192 | 62 | 4 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-04 | 192 | 62 | 4 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 192 | 62 | 4 | 3617d2bc7e33d981f3ec349e9962d8d4bd822fbd | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-04 | 192 | 62 | 4 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 193 | 62 | 4 | 5182284dfa7c94027e94172e08f78c86b95d63f4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 193 | 62 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 193 | 62 | 4 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 193 | 62 | 4 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-04 | 193 | 62 | 4 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 193 | 62 | 4 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | 5099e6ad7c19e5f8b73449d904aaefd97f1b1959 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | 71734ef7b34ab33b349595368176fa0e1175d4d0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 195 | 62 | 4 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 1.60e-04 | 196 | 62 | 4 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 196 | 62 | 4 | 3dc6394c5de1f875a19ad0e8799827fad29f8f02 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 196 | 62 | 4 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.60e-04 | 196 | 62 | 4 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.63e-04 | 197 | 62 | 4 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | COVID-19_Severe|World / Disease group, lineage and cell class | 1.63e-04 | 197 | 62 | 4 | f0824f98269bdcd8463873beaf222df8f0caa468 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 197 | 62 | 4 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | PBMC-Severe|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-04 | 197 | 62 | 4 | af10b5e6e959e2ced01ad066f906941bc4194cc3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 197 | 62 | 4 | 0b2ad6a933ff1a325649cc8f139380fd158a1d42 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 197 | 62 | 4 | 5f6fce382f273e789ffbb75b63e9b4e87519918e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | b67ffd27d386c8186ef71ecdac96a462504507f0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | 470e23dee4ca35e1fd021b7cdd58fcbc90639837 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.66e-04 | 198 | 62 | 4 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 198 | 62 | 4 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 198 | 62 | 4 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| Drug | AC1LCUXJ | 2.49e-10 | 5 | 62 | 4 | CID000656425 | |
| Drug | 5'-deoxy-5'-chloroformycin | 7.44e-10 | 6 | 62 | 4 | CID000126430 | |
| Drug | Promonta | 1.73e-09 | 7 | 62 | 4 | CID000108494 | |
| Drug | 5'-methylthiotubercidin | 6.22e-09 | 9 | 62 | 4 | CID000188350 | |
| Drug | 3,5-dimethylphenyl isocyanate | 1.92e-08 | 3 | 62 | 3 | CID000521488 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 1.92e-08 | 3 | 62 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 1.92e-08 | 3 | 62 | 3 | CID000191554 | |
| Drug | hydan | 1.92e-08 | 3 | 62 | 3 | CID000008360 | |
| Drug | EHMF | 1.92e-08 | 3 | 62 | 3 | CID000033931 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 1.92e-08 | 3 | 62 | 3 | CID000147839 | |
| Drug | pyridoxal 5'-methylenephosphonate | 1.92e-08 | 3 | 62 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 1.92e-08 | 3 | 62 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 1.92e-08 | 3 | 62 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 1.92e-08 | 3 | 62 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 1.92e-08 | 3 | 62 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 1.92e-08 | 3 | 62 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 1.92e-08 | 3 | 62 | 3 | CID000446801 | |
| Drug | NSC758405 | 1.92e-08 | 3 | 62 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 1.92e-08 | 3 | 62 | 3 | CID000151920 | |
| Drug | riboflavin tetraacetate | 1.92e-08 | 3 | 62 | 3 | CID000094186 | |
| Drug | pyridoxal phosphoglucose | 1.92e-08 | 3 | 62 | 3 | CID000196007 | |
| Drug | 2,5-dimethyl-3-furanone | 1.92e-08 | 3 | 62 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 1.92e-08 | 3 | 62 | 3 | CID000011459 | |
| Drug | AC1L19D1 | 2.43e-08 | 12 | 62 | 4 | CID000000494 | |
| Drug | galocitabine | 7.68e-08 | 4 | 62 | 3 | CID000065950 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 7.68e-08 | 4 | 62 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 7.68e-08 | 4 | 62 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 7.68e-08 | 4 | 62 | 3 | CID000094262 | |
| Drug | Mem-CC | 7.68e-08 | 4 | 62 | 3 | CID003081269 | |
| Drug | 5-deoxyribose-1-phosphate | 7.68e-08 | 4 | 62 | 3 | CID000135786 | |
| Drug | ingliforib | 7.68e-08 | 4 | 62 | 3 | CID006451325 | |
| Drug | uric acid riboside | 7.68e-08 | 4 | 62 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 7.68e-08 | 4 | 62 | 3 | CID000125259 | |
| Drug | BCIp4A | 7.68e-08 | 4 | 62 | 3 | CID000192417 | |
| Drug | pyridoxal diphosphate | 7.68e-08 | 4 | 62 | 3 | CID000125696 | |
| Drug | 3'-chloromethotrexate | 7.68e-08 | 4 | 62 | 3 | CID000097703 | |
| Drug | 5-methylthioribose-1-phosphate | 8.85e-08 | 16 | 62 | 4 | CID000000465 | |
| Drug | heptulose-2-P | 1.92e-07 | 5 | 62 | 3 | CID000124823 | |
| Drug | m-anisidine | 1.92e-07 | 5 | 62 | 3 | CID000010824 | |
| Drug | 6-FPLP | 1.92e-07 | 5 | 62 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 1.92e-07 | 5 | 62 | 3 | CID009576855 | |
| Drug | 2-hydroxypropylphosphonate | 1.92e-07 | 5 | 62 | 3 | CID000441028 | |
| Drug | DHPBU | 1.92e-07 | 5 | 62 | 3 | CID000125914 | |
| Drug | 6-FDPL | 1.92e-07 | 5 | 62 | 3 | CID000129578 | |
| Drug | 5'-isobutylthioinosine | 1.92e-07 | 5 | 62 | 3 | CID003080910 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 1.92e-07 | 5 | 62 | 3 | CID003082179 | |
| Drug | GlcMan | 1.92e-07 | 5 | 62 | 3 | CID000152120 | |
| Drug | U66985 | 1.92e-07 | 5 | 62 | 3 | CID000127224 | |
| Drug | indirubin-5-sulphonate | 1.92e-07 | 5 | 62 | 3 | CID005288641 | |
| Drug | AC1O3M08 | 1.92e-07 | 5 | 62 | 3 | CID006331955 | |
| Drug | 6-amino-5-bromouracil | 1.92e-07 | 5 | 62 | 3 | CID000080578 | |
| Drug | etafenone | 1.92e-07 | 5 | 62 | 3 | CID000003275 | |
| Drug | ddEtUrd | 1.92e-07 | 5 | 62 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 1.92e-07 | 5 | 62 | 3 | CID000125618 | |
| Drug | acyclonucleoside | 2.34e-07 | 20 | 62 | 4 | CID000466144 | |
| Drug | CV-araU | 3.82e-07 | 6 | 62 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 3.82e-07 | 6 | 62 | 3 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 3.82e-07 | 6 | 62 | 3 | CID006438602 | |
| Drug | DNPP | 3.82e-07 | 6 | 62 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 3.82e-07 | 6 | 62 | 3 | CID000082693 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 3.82e-07 | 6 | 62 | 3 | CID000152984 | |
| Drug | EdUMP | 3.82e-07 | 6 | 62 | 3 | CID003085112 | |
| Drug | NSC-97433 | 3.82e-07 | 6 | 62 | 3 | CID000001803 | |
| Drug | 5-n-propylthioadenosine | 3.82e-07 | 6 | 62 | 3 | CID000656428 | |
| Drug | AzddCyd | 3.82e-07 | 6 | 62 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 3.82e-07 | 6 | 62 | 3 | CID000065561 | |
| Drug | AR-L57 | 3.82e-07 | 6 | 62 | 3 | CID000156890 | |
| Drug | Carbocyclic Ivdu | 3.82e-07 | 6 | 62 | 3 | CID006439191 | |
| Drug | AC1L8YNX | 4.25e-07 | 23 | 62 | 4 | CID000410238 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 6.68e-07 | 7 | 62 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 6.68e-07 | 7 | 62 | 3 | CID003080803 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 6.68e-07 | 7 | 62 | 3 | CID000356019 | |
| Drug | heptenitol | 6.68e-07 | 7 | 62 | 3 | CID000188267 | |
| Drug | 3-methylcytidine | 6.68e-07 | 7 | 62 | 3 | CID000159649 | |
| Drug | AC1L3372 | 6.68e-07 | 7 | 62 | 3 | CID000108025 | |
| Drug | 1 Gpt | 6.68e-07 | 7 | 62 | 3 | CID000101247 | |
| Drug | formycins | 6.68e-07 | 7 | 62 | 3 | CID000512867 | |
| Drug | 5'-methylthioinosine | 6.68e-07 | 7 | 62 | 3 | CID000161214 | |
| Drug | hydantocidin | 6.68e-07 | 7 | 62 | 3 | CID000125429 | |
| Drug | CID5288653 | 9.72e-07 | 28 | 62 | 4 | CID005288653 | |
| Drug | AC1NUVX5 | 1.07e-06 | 8 | 62 | 3 | CID005461894 | |
| Drug | 6-methoxypurine | 1.07e-06 | 8 | 62 | 3 | CID000070632 | |
| Drug | 6-methylpurine | 1.07e-06 | 8 | 62 | 3 | CID005287547 | |
| Drug | amorphin | 1.07e-06 | 8 | 62 | 3 | CID000122792 | |
| Drug | Etafenone [inn] | 1.07e-06 | 8 | 62 | 3 | CID000066659 | |
| Drug | 6-benzyl-2-thiouracil | 1.60e-06 | 9 | 62 | 3 | CID000685814 | |
| Drug | alpha-maltosyl fluoride | 1.60e-06 | 9 | 62 | 3 | CID000194237 | |
| Drug | 5-Iodoribose 1-phosphate | 1.60e-06 | 9 | 62 | 3 | CID003035973 | |
| Drug | 5'-iodo-5'-deoxyadenosine | 1.60e-06 | 9 | 62 | 3 | CID000107502 | |
| Drug | AC1L1AOE | 1.69e-06 | 32 | 62 | 4 | CID000001078 | |
| Drug | AC1LCV0V | 1.69e-06 | 32 | 62 | 4 | CID000656468 | |
| Drug | 8-azidoadenosine 5'-monophosphate | 2.28e-06 | 10 | 62 | 3 | CID000124726 | |
| Drug | 2,6-dihydroxypyridine | 2.28e-06 | 10 | 62 | 3 | CID000069371 | |
| Drug | 6-methyluridine | 2.28e-06 | 10 | 62 | 3 | CID000092887 | |
| Drug | UDP-pyridoxal | 2.28e-06 | 10 | 62 | 3 | CID000126789 | |
| Drug | AC1NSKFN | 2.75e-06 | 36 | 62 | 4 | CID005311324 | |
| Drug | I TU | 3.08e-06 | 37 | 62 | 4 | CID000001830 | |
| Drug | glucosyl fluoride | 3.12e-06 | 11 | 62 | 3 | CID000150967 | |
| Drug | Cid 11299980 | 3.12e-06 | 11 | 62 | 3 | CID009856533 | |
| Drug | 9 Da | 3.12e-06 | 11 | 62 | 3 | CID005287565 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 4.44e-07 | 8 | 60 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 4.44e-07 | 8 | 60 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 4.44e-07 | 8 | 60 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 4.44e-07 | 8 | 60 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 9.49e-07 | 10 | 60 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 9.49e-07 | 10 | 60 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | hemoglobin A1 measurement | 1.01e-05 | 520 | 60 | 8 | EFO_0007629 | |
| Disease | word list delayed recall measurement, memory performance | 4.18e-05 | 33 | 60 | 3 | EFO_0004874, EFO_0006805 | |
| Disease | Hypertrophic Cardiomyopathy | 2.16e-04 | 57 | 60 | 3 | C0007194 | |
| Disease | functional brain measurement | 6.31e-04 | 82 | 60 | 3 | EFO_0007849 | |
| Disease | L lactate dehydrogenase measurement | 1.28e-03 | 26 | 60 | 2 | EFO_0004808 | |
| Disease | myeloperoxidase measurement | 1.28e-03 | 26 | 60 | 2 | EFO_0005243 | |
| Disease | Glycogen Storage Disease | 1.38e-03 | 27 | 60 | 2 | C0017919 | |
| Disease | cholesteryl ester 14:0 measurement | 1.38e-03 | 27 | 60 | 2 | EFO_0010340 | |
| Disease | Primary familial dilated cardiomyopathy | 1.71e-03 | 30 | 60 | 2 | cv:C0340427 | |
| Disease | serum alanine aminotransferase measurement | 1.87e-03 | 869 | 60 | 7 | EFO_0004735 | |
| Disease | red blood cell density measurement | 2.00e-03 | 880 | 60 | 7 | EFO_0007978 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGDNVEEMDSMVGKI | 311 | P54793 | |
| MVGMGQKDSYVGDEA | 46 | P68133 | |
| LVDVEEMNYMAAEGE | 491 | P33121 | |
| EMNYMAAEGEGEVCV | 496 | P33121 | |
| MVGMGQKDSYVGDEA | 46 | P62736 | |
| EVEMAGIEYMNDDPG | 246 | Q8N9N2 | |
| YEMFGDEEVMCLNGN | 1081 | P08603 | |
| VGYDAMAGDFVNMVE | 501 | P10809 | |
| LIDMNAEGDETGVMD | 1186 | O60610 | |
| ADEMDVMLGQEVGYS | 206 | O43143 | |
| TMIADDMSNYDEEGA | 221 | Q96GG9 | |
| MQTAADKCEEMEEGY | 1026 | Q13625 | |
| EEEEGGSYEAMMDDQ | 6 | Q86Y37 | |
| MAENEAGKEEQEGME | 846 | Q5T481 | |
| DDEEMCHEEMYGNEE | 176 | Q9ULW6 | |
| MAKDVGNVVEAMYGD | 131 | Q9Y570 | |
| GAIGSVYDMDDDEMD | 936 | Q8TEW8 | |
| EEAVDMDYGDMAVDV | 211 | Q9Y4B6 | |
| MDYGDMAVDVVDGDQ | 216 | Q9Y4B6 | |
| TVMYGAMLQADDEDD | 1306 | Q9Y4B6 | |
| RNDKYAGEEGMIEDM | 576 | Q86U86 | |
| LDVASEMEQVDGGYM | 3276 | Q9UKN7 | |
| NMIADDMSNYDEEGA | 221 | Q6PH85 | |
| GQYDDMGENMTDDPR | 3421 | Q9Y6V0 | |
| MSSEVDVGGYMSDGD | 811 | Q8IVL0 | |
| EMEGDGVIDPGMEYV | 371 | Q9H8E8 | |
| ADSEGGEEYNAMMKN | 466 | Q76FK4 | |
| QEGEEMETDMDGVQC | 486 | Q7Z6Z7 | |
| SGEDEMITMDNAEEY | 2431 | Q9ULT8 | |
| MTSMQDGYQGSEEDV | 246 | Q6ZMU1 | |
| EENEEENLAMAVGMG | 1871 | Q8TD26 | |
| EMMEEIDYDHDGTVS | 201 | Q9Y6T7 | |
| DSYDEDFAGGMDTDM | 196 | Q6UXB0 | |
| RYDSGQDLDEEGMNM | 446 | Q99615 | |
| AAMVEMADGYAVDRA | 421 | P14866 | |
| MYGRPQAEMEQEAGE | 1 | Q5JT82 | |
| GLDEVAMGEMEADVQ | 106 | Q8IWT3 | |
| EMTDCDEGGEYDGMQ | 646 | O00418 | |
| QAAMEGYEVTTMDEA | 251 | P23526 | |
| MGDKKYEDMEGEENG | 11 | Q99590 | |
| AEMEYSIAEGDGADM | 301 | Q9ULB4 | |
| LMDDYQEMNEGFGEG | 376 | Q2WGJ9 | |
| QEMMEEQGYSEEEIR | 71 | A6NNA2 | |
| DVEYNNMELEEGELM | 561 | O94972 | |
| ALIMDEVDGMAGNED | 716 | P35251 | |
| YGAAMVVMAFDEEGQ | 491 | Q99707 | |
| GNEMINGEDEMEMYD | 791 | P35712 | |
| SDYEGQEEEMNGTKM | 636 | Q9UK61 | |
| MVGMGQKDSYVGDEA | 46 | P68032 | |
| SKIMDDDSYGVDGMD | 611 | Q9UKI8 | |
| EMYEEFQDVGLMTGD | 201 | P42285 | |
| GTMDGANVEMAEEAG | 691 | P11217 | |
| EDGYDLEAVLAAMGM | 291 | Q9UIV8 | |
| EYFGLDPEDVDVMMG | 361 | O15270 | |
| LDGEYEVAMQEMEEC | 311 | Q15022 | |
| GTMDGANVEMAEEAG | 691 | P11216 | |
| GYSMGAGSDADMEAD | 106 | Q6N022 | |
| MMGSNDYGCDGDEDD | 661 | Q92994 | |
| GMNKGGMNDDEDFYD | 351 | Q9UPT8 | |
| GMNDDEDFYDEDMGD | 356 | Q9UPT8 | |
| RQGYEEGLVDEAMEM | 316 | F5GYI3 | |
| GFDQEMAEKVGSYME | 371 | Q86VQ6 | |
| MVTLQEEDAGEYGCM | 91 | Q86YW5 | |
| MAEGEGYFAMSEDEL | 1 | Q96IP4 | |
| GTMDGANVEMAEEAG | 691 | P06737 | |
| GQVSQTDEEDMGMTY | 581 | Q6IA69 |